Virus Vectors for Production of Pharmaceuticals in Plants
Journal: Austin Journal of Clinical Immunology (Vol.1, No. 4)Publication Date: 2014-06-06
Authors : Kathleen Hefferon;
Page : 1-3
Keywords : Plant-based vaccines; Virus expression vector; Immune response;
Abstract
Over the past two decades, plants have been developed as inexpensive, efficacious and safe production platforms for vaccines and other biopharmaceuticals. One of the up and coming ways to generate vaccines quickly and in large amounts in plants is through the use of deconstructed plant virus expression vectors. This review discusses several of the state-of-the-art plant virus expression systems that have been engineered for vaccine production. Recent advances in tobamovirus, cucumovirus, geminivirus, and several other virus expression vector systems are described in this review, and examples of vaccines generated from each are described.
Other Latest Articles
- RELIGIOUS TRANSFORMATIONS IN CONTEMPORARY INFORMATION SOCIETY
- ON THE HISTORY OF HIGHER PEDAGOGICAL EDUCATION FORMATION IN KAZAKHSTAN
- Molecular Network of NLRP3 Inflammasome Activation-Responsive Genes in a Human Monocyte Cell Line
- ORTHODOX THEOLOGY’S CRITICAL VIEWS ON THE CATHOLIC DOCTRINE OF THE FILIOQUE
- Relationship between Mast Cells and Autoimmune Diseases
Last modified: 2016-07-21 20:27:57